Comparison of low dose versus high dose Botulinum toxin (Dysport) in the treatment of children with hemiplegic cerebral palsy.
Completed
- Conditions
- ervous system diseases: Cerebral palsyNervous System DiseasesCerebral palsy
- Registration Number
- ISRCTN37525568
- Lead Sponsor
- HS R&D Regional Programme Register - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Children with hemiplegic cerebral palsy
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Impairment measure using gait analysis<br>2. Gastrocnemius muscle length was calculated at each visit using the method described by Eames and used as primary outcome measure
- Secondary Outcome Measures
Name Time Method Secondary outcome variable was maximum ankle angle measured during stance and swing phases.